FilingIndex
8-KThe WireRoutine

Shareholder Vote

Filed May 5, 2025 · 1y ago · Accession 0000028823-25-000051

Plain English

Material event — a significant development the company must disclose promptly.

Read the source below for the full document.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): April 30, 2025 Diebold Nixdorf, Incorporated   (Exact name of registrant as specified in its charter) _________________________________________________  Delaware   1-4879   34-0183970           (State or other jurisdiction of incorporation)   (Commission File Number)   (I.R.S. Employer  Identification No.)           350 Orchard Avenue NE       North Canton, Ohio 44720-2556           (Address of principal executive offices)       (Zip Code) Registrant's telephone number, including area code: ( 330 )  490-4000 Not Applicable   Former name or former address, if changed since last report Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the Registrant under any of the following provisions: ☐       Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ☐       Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ☐       Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) ☐       Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbol Name of each exchange on which registered Common Stock, $0.01 par value per share DBD New York Stock Exchange Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company  ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐ Item 5.07. Submission of Matters to a Vote of Security Holders At the Diebold Nixdorf, Incorporated (the “Company”) Annual Meeting of Stockholders held on April 30, 2025, the Company’s stockholders: (1) elected each of the Board’s eight (8) nominees for director to serve one-year terms or until the election and qualification of a successor; (2) ratified the appointment of KPMG LLP as the Company’s independent registered public accounting firm for the year 2025; and (3) approved, on an advisory basis, the Company’s named executive officer compensation. These proposals are described in more detail in the Company’s definitive proxy statement on Schedule 14A filed March 14, 2025. Set forth below are the final voting results for each proposal: Proposal 1: Election of each of the Board’s eight (8) nominees for director Nominee For Against Abstain Broker Non-Vote Arthur F. Anton 35,466,134 455,825 1,959 304,110 Patrick J. Byrne 35,908,904 12,769 2,245 304,110 Matthew J. Espe 35,458,899 463,060 1,959 304,110 Mark Gross 35,002,401 891,987 29,530 304,110 Maura A. Markus 35,918,977 2,696 2,245 304,110 Octavio Marquez 35,920,714 1,329 1,875 304,110 David H. Naemura 35,919,051 2,908 1,959 304,110 Dr. Colin J. Parris 35,896,022 25,651 2,245 304,110 Proposal 2: Ratification of Appointment of KPMG LLP For Against Abstain 36,131,645 93,825 2,558 Proposal 3: Advisory Approval of Named Executive Officer Compensation For Against Abstain Broker Non-Vote 35,496,906 35,320 391,692 304,110 SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.           Diebold Nixdorf, Incorporated Date: May [5], 2025 By:   /s/ Elizabeth C. Radigan     Name:   Elizabeth C. Radigan     Title:   Executive Vice President, Chief Legal Officer and Secretary
Filing details
Ticker
DBD
CIK
28823
Form type
8-K
Filing date
May 5, 2025
Report date
Apr 30, 2025
Document
dbd-20250430.htm
Size
209 KB